Home›Stock Screener›Aspira Pathlab›Quarterly Results

Aspira Pathlab Quarterly Results

Latest Quarter Net Profit
₹1 Cr
QMar 2025
Quarterly Results

Aspira Pathlab quarterly results. In Mar 2025, Aspira Pathlab (ASPIRA) reported revenue ₹6 Cr and net profit ₹1 Cr — revenue +50.0% YoY. View Aspira Pathlab 52-week for the annual high/low range and current price position.

ASPIRA Quarterly Results — Revenue, Profit & EPS Highlights

Aspira Pathlab latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit ASPIRA share price.

  • Revenue of ₹6 Cr in Mar 2025 (+20.0% vs Jun 2025, +50.0% vs Mar 2024)
  • Net Profit of ₹1 Cr in Mar 2025 (+200.0% vs Mar 2024)
  • EBITDA of ₹1 Cr in Mar 2025 (+0.0% vs Jun 2025)
  • Operating Margin of 16.0% in Mar 2025 (+3.0pp vs Jun 2025)
  • Earnings Per Share of ₹0.66 in Mar 2025 (+61.0% vs Jun 2025)

Aspira Pathlab Quarterly Results — Revenue, EBITDA, Net Profit & EPS

ASPIRA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2025 Jun 2025 Sept 2024 Mar 2024 Jun 2024 QoQ YoY
Revenue (₹ Cr) 6 5 6 4 5 20.0% 50.0%
Net Profit (₹ Cr) 1 0 1 -1 0 - -
EBITDA (₹ Cr) 1 1 1 0 0 - -
EPS (₹) 0.66 0.41 0.96 -0.49 0.05 - -
Operating Margin (%) 16.0% 13.0% 21.0% -5.0% 6.0% - -

ASPIRA Share Price Trend — 1-Year Movement Across Quarterly Results

Aspira Pathlab 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore ASPIRA share price charts to track price trends across different timeframes.

Profitability Ratios

Profit Margin 16.7%
EBITDA Margin 16.7%
Operating Margin 16.0%
ROE (Annual) 33.3%

Balance Sheet Highlights

Total Assets ₹18 Cr
Total Equity ₹12 Cr
Current Assets ₹ Cr
Current Liabilities ₹3 Cr

Cash Flow Analysis

Operating Cash Flow ₹2 Cr
Investing Cash Flow ₹0 Cr
Financing Cash Flow ₹-1 Cr
Net Cash Flow ₹1 Cr

Current Market Data

Current Price ₹131.00
Exchange BSE
Last Updated Nov 20, 2026

ASPIRA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Aspira Pathlab latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1884.9 16,617 1,995 +10.6% - 12.0% 227.1
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11180.5 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4689.5 4,111 364 +27.7% +42.2% 8.9% 407.4
Apollo Hospitals
Sept 2026
₹132,281.88 Cr 9200.0 7,673 660 +15.2% - 8.6% 209.9
Laurus Labs
Sept 2026
₹125,946.78 Cr 2294.6 2,219 436 +21.7% - 19.6% 280.9
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores